Abstract:Some novel complexes incorporating 4,6‐dimethyl‐N‐(octahydro‐2H‐benzimidazol‐2‐ylidene)pyrimidin‐2‐amine ligands were synthesized and their structures were elucidated by different Physicochemical and computational techniques. Moreover, all the new compounds were tested in vitro against microbial strains, free radicals, and cancer cell lines. Furthermore, DNA interaction with the inspected complexes was investigated. New Cu (II), VO (II), Ag(I), and Pd (II)‐[BIP = 4,6‐dimethyl‐N‐(octahydro‐2H‐benzimidazol‐2‐ylidene)pyrimidin‐2‐amine] chelates have been synthesized by the reaction of BIP ligand resulting from the condensation of benzimidazole guanidine as well as acetylacetone with tested metal salts. The suggested structures of prepared compounds have been investigated spectroscopically through (FT‐IR, NMR, Mass spectra, and UV–Vis spectra), CHN analyses, conductivity, pH stability as well asmagnetic moment measurements. TGA studies have been also studied to govern the thermal behavior, stability, and decomposition of the metal chelates. Structural study of the tested chelates exposed their chemical transformation of ligand by chelation with the studied metals. The studies predicted a hexa‐coordinated geometry for the Cu and VO chelates, whereas tetra‐coordinated for the Ag and Pd chelates. DFT/B3LYP theoretical method was applied to obtain optimized geometry, molecular electrostatic potential (MEP) surface, and HOMO‐LUMO analysis for tested compounds. For estimation in the in vitro study, all the tested compounds have been screened for their biochemical features, including antioxidant, antimicrobial performances, and cytotoxicity. The antioxidant performance of prepared molecules has been studied by DPPH study and all the tested chelates displayed close antioxidant performance against the standard drugs. The cytotoxic analysis of tested compounds has been estimated against various cancer cell lines: (Hep‐G2, HCT‐116, and MCF‐7) using MTT analysis as well as calculated the cell viability for the corresponding human cell. The DNA binding capability for the tested compounds has been evaluated through absorption spectroscopic, viscosity estimation, as well as gel electrophoresis. The outcomes displayed a good binding tendency through the binding constant from 1.01 × 104 to 1.99 × 104 M−1 in the order BIPCu> BIPVO > BIPPd > BIPAg, respectively. Finally, docking simulation results indicated that the complexes were located in the intercalation site of DNA and confirmed experimental findings.

Investigation of half-sandwich platinum group metal complexes featuring benzamide derived ligands and their diazido derivatives: Synthesis, molecular structures and biological studies

Structure elucidation {single X-ray crystal diffraction studies, Hirshfeld surface analysis, DFT} and antibacterial studies of 1,2-benzothiazine metal complexes

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Ruthenium, rhodium and iridium complexes containing diazafluorene derivative ligands: synthesis and biological studies

Preparation, Characterization, Antioxidant and Antibacterial Studies of New Metal (II) Complexes with Schiff Base for 3-amino-1-phenyl-2- pyrazoline-5-one

Synthesis, characterization, DFT computational studies and biological activity of transition metal complexes derived from 4-(((6-nitrobenzo[d]thiazol-2-yl)imino)methyl)benzene-1,3-diol

Experimental and theoretical investigation into the design of nickel(II), copper(II), and zinc(II) complexes substituted with pyrazole ligand

Synthesis, Characterization and Biological Studies of Some Transition Metal Complexes with Pyrazine Schiff Base Hydra zone Ligand

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Exploring the therapeutic potentials of bidentate ligands derived from benzohydrazide and their mononuclear transition metal complexes: insights from computational studies

Design, preparation, physicochemical characterization, structural conformational, biological evaluation, and DNA interaction for some new benzimidazole complexes

Synthesis and Spectral Studies of New Azomethine Metal Complexes With Biological Activity and Docking Studies Utilizing 3‐Methylpyridin‐2‐Amine as a Complexing Agent

Palladium(II) complexes of thiobenzamide derivative ligands: Synthesis, crystal structure, supramolecular architecture, Hirshfeld surface analysis, and in vitro antibacterial and antifungal activities

Biological Studies and Spectroscopic investigation of 4-Methyl Benzylimine Schiff Base Metal Complexes

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Ligation and Antimicrobial Studies on Synthetic Metal Complexes of Novel Asymmetric Polydentate Hydrazonic Ligand Incorporating Oxime Moiety Derived Arom 4,6-Diacetylresorcinol

Anticancer Study on Ir III and Rh III Half-Sandwich Complexes with the Bipyridylsulfonamide Ligand

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine